Ken Griffin Ideaya Biosciences, Inc. Put Options Transaction History

Citadel Advisors LLC

  • $509 Billion
  • Q1 2024

Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024
SELL
$34.2 - $47.13 $47,880 - $65,982
-1,400 Reduced 35.9%
2,500 $109,000
Q4 2023

Feb 14, 2024
SELL
$24.59 - $35.83 $137,704 - $200,648
-5,600 Reduced 58.95%
3,900 $138,000
Q3 2023

Nov 14, 2023
SELL
$21.07 - $29.77 $4,214 - $5,954
-200 Reduced 2.06%
9,500 $256,000
Q2 2023

Aug 14, 2023
BUY
$13.33 - $25.53 $129,301 - $247,641
9,700 New
9,700 $227,000
Q4 2022

Feb 14, 2023
BUY
$14.47 - $18.17 $5,788 - $7,268
400 New
400 $7,000

Others Institutions Holding IDYA

# of Institutions
206
Shares Held
71.2M
Call Options Held
29.8K
Put Options Held
8.5K
View Full List

About IDEAYA Biosciences, Inc.

IDYA Quotes by TradingView
  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.74B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email